Citadel Advisors’s National Healthcare NHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.05M Sell
9,700
-2,900
-23% -$532K ﹤0.01% 6490
2026
Q1
$2.01M Buy
12,600
+6,700
+114% +$1.03M ﹤0.01% 6055
2025
Q4
$809K Buy
+5,900
New +$762K ﹤0.01% 7891
2025
Q2
Sell
-100
Closed -$9.28K 14206
2025
Q1
$9.28K Buy
+100
New +$9.69K ﹤0.01% 13604
2024
Q4
Sell
-1,100
Closed -$138K 15097
2024
Q3
$138K Buy
1,100
+500
+83% +$62.9K ﹤0.01% 10674
2024
Q2
$65K Buy
600
+100
+20% +$9.75K ﹤0.01% 11464
2024
Q1
$47.3K Buy
+500
New +$47.3K ﹤0.01% 12224

Other funds holding NHC

Citadel Advisors's NHC Position: Q2 2026 in Review

Citadel Advisors sold out of National Healthcare (NHC) in Q2 2026, closing a stake of 7,942 shares — an estimated $1.46M sold.

Citadel Advisors first reported a position in NHC in Q4 2015 and held it in 30 quarters. The position peaked at $5.84M in Q1 2023. 249 funds tracked by Wall St. Rank hold NHC as of Q2 2026.

  • Citadel Advisors reported no remaining National Healthcare position as of Q2 2026 after selling out during the quarter.
  • Citadel Advisors sold 7,942 National Healthcare shares in Q2 2026, an estimated $1.46M.
  • Citadel Advisors first reported a position in National Healthcare in Q4 2015 and held it in 30 quarters.
  • Citadel Advisors's National Healthcare position peaked at $5.84M in Q1 2023.
  • 249 funds tracked by Wall St. Rank held National Healthcare as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.